Cargando…
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
BACKGROUND: Few specific medications have been proven effective for the treatment of patients with severe coronavirus disease 2019 (COVID-19). Here, we tested whether high-dose vitamin C infusion was effective for severe COVID-19. METHODS: This randomized, controlled, clinical trial was performed at...
Autores principales: | Zhang, Jing, Rao, Xin, Li, Yiming, Zhu, Yuan, Liu, Fang, Guo, Guangling, Luo, Guoshi, Meng, Zhongji, De Backer, Daniel, Xiang, Hui, Peng, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794643/ https://www.ncbi.nlm.nih.gov/pubmed/33420963 http://dx.doi.org/10.1186/s13613-020-00792-3 |
Ejemplares similares
-
High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases
por: Guo, Guangling, et al.
Publicado: (2022) -
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial
por: Liu, Fang, et al.
Publicado: (2020) -
Vitamin D Deficiency in Critically Ill
por: Angurana, Suresh Kumar, et al.
Publicado: (2017) -
Sex-Specific Catabolic Metabolism Alterations in the Critically Ill following High Dose Vitamin D
por: Chary, Sowmya, et al.
Publicado: (2022) -
Evaluation of gentamicin first-dose pharmacokinetics in septic critically ill patients: pilot study
por: Pereira, JC Gonçalves, et al.
Publicado: (2009)